Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer

Clinical trial NCT01251874 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01251874
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Breast Carcinoma Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 Triple-Negative Breast Carcinoma

Start date: 2010-11-22
Primary completion: 2024-09-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.